SG11201704815VA - New metal complexes of nocardamine and their use in pharmaceutical compositions - Google Patents
New metal complexes of nocardamine and their use in pharmaceutical compositionsInfo
- Publication number
- SG11201704815VA SG11201704815VA SG11201704815VA SG11201704815VA SG11201704815VA SG 11201704815V A SG11201704815V A SG 11201704815VA SG 11201704815V A SG11201704815V A SG 11201704815VA SG 11201704815V A SG11201704815V A SG 11201704815VA SG 11201704815V A SG11201704815V A SG 11201704815VA
- Authority
- SG
- Singapore
- Prior art keywords
- nocardamine
- pharmaceutical compositions
- metal complexes
- new metal
- new
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462095212P | 2014-12-22 | 2014-12-22 | |
| PCT/IL2015/051243 WO2016103260A1 (en) | 2014-12-22 | 2015-12-22 | New metal complexes of nocardamine and their use in pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201704815VA true SG11201704815VA (en) | 2017-07-28 |
Family
ID=55221469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201704815VA SG11201704815VA (en) | 2014-12-22 | 2015-12-22 | New metal complexes of nocardamine and their use in pharmaceutical compositions |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20190022103A1 (en) |
| EP (1) | EP3236970B1 (en) |
| JP (2) | JP6609320B2 (en) |
| KR (1) | KR102417080B1 (en) |
| CN (1) | CN107206091A (en) |
| AU (1) | AU2015369552B2 (en) |
| CA (1) | CA2971824A1 (en) |
| DK (1) | DK3236970T3 (en) |
| IL (1) | IL252739B (en) |
| MX (1) | MX2017008234A (en) |
| SG (1) | SG11201704815VA (en) |
| WO (1) | WO2016103260A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3236970T3 (en) * | 2014-12-22 | 2021-01-18 | Mordechai Chevion | NEW METAL COMPLEXES OF NOCARDAMIN AND THEIR USE IN PHARMACOLOGICAL COMPOSITIONS |
| EP3383415B1 (en) | 2015-12-01 | 2021-03-31 | Cornell University | Use of mitochondrial iron chelators for treatment of chronic obstructive pulmonary disease |
| AU2021255924A1 (en) * | 2020-04-14 | 2022-11-17 | Vector Vitale Ip Llc | Method of preventing or treating viral infections |
| CN114452285B (en) * | 2022-02-17 | 2022-11-25 | 中国中医科学院中药研究所 | Application of IL-17A antagonist in treating diabetic ulcer |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3471476A (en) * | 1964-05-18 | 1969-10-07 | Tino Gaeumann | Trihydroxamic acids |
| EP0325559B1 (en) * | 1988-01-20 | 1993-12-15 | Ciba-Geigy Ag | Process for the preparation of complex compounds |
| IL91047A (en) | 1989-07-19 | 1993-06-10 | Yissum Res Dev Co | Zinc complexes for the treatment of free radical- induced diseases |
| US5618838A (en) | 1993-06-18 | 1997-04-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Gallium complexes for the treatment of free radical-induced diseases |
| IL106064A (en) * | 1993-06-18 | 1997-11-20 | Yissum Res Dev Co | Gallium complexes for the treatment of free radical-induced diseases |
| US5493053A (en) * | 1994-12-21 | 1996-02-20 | University Of Florida Research Foundation, Inc. | Method for preparing desferrioxamine B and homologs thereof |
| WO2004060490A1 (en) * | 2003-01-07 | 2004-07-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent |
| US8680148B2 (en) * | 2006-08-11 | 2014-03-25 | University Of Washington | Metallo-desferrioxamine complexes and their use in the treatment of bacterial infections |
| DE102007008655A1 (en) | 2007-02-20 | 2008-08-21 | Henkel Ag & Co. Kgaa | Siderophore-metal complexes as bleach catalysts |
| ES2383939T3 (en) * | 2008-01-25 | 2012-06-27 | Sharp Kabushiki Kaisha | Device and mobile station program |
| EP2467135B1 (en) * | 2009-08-19 | 2017-02-01 | Mordechai Chevion | Desferrioxamine-metal complexes for the treatment of immune-related disorders |
| DE102010028742A1 (en) * | 2010-05-07 | 2011-11-10 | Henkel Ag & Co. Kgaa | Particulate washing agent, useful in textile washing, comprises a manganese complex with a ligand in the form of desferrioxamine E and/or desferrioxamine B |
| KR101628586B1 (en) * | 2012-08-28 | 2016-06-08 | (주)오리지날 바이오메디칼스 | The controlled release method for a pharmaceutical composition composed of chelating complex micelles |
| DK3236970T3 (en) * | 2014-12-22 | 2021-01-18 | Mordechai Chevion | NEW METAL COMPLEXES OF NOCARDAMIN AND THEIR USE IN PHARMACOLOGICAL COMPOSITIONS |
-
2015
- 2015-12-22 DK DK15828387.9T patent/DK3236970T3/en active
- 2015-12-22 CA CA2971824A patent/CA2971824A1/en active Pending
- 2015-12-22 CN CN201580075443.XA patent/CN107206091A/en active Pending
- 2015-12-22 US US15/538,513 patent/US20190022103A1/en not_active Abandoned
- 2015-12-22 MX MX2017008234A patent/MX2017008234A/en unknown
- 2015-12-22 WO PCT/IL2015/051243 patent/WO2016103260A1/en active Application Filing
- 2015-12-22 KR KR1020177020380A patent/KR102417080B1/en active IP Right Grant
- 2015-12-22 JP JP2017551396A patent/JP6609320B2/en active Active
- 2015-12-22 SG SG11201704815VA patent/SG11201704815VA/en unknown
- 2015-12-22 AU AU2015369552A patent/AU2015369552B2/en active Active
- 2015-12-22 EP EP15828387.9A patent/EP3236970B1/en active Active
-
2017
- 2017-06-07 IL IL252739A patent/IL252739B/en active IP Right Grant
-
2019
- 2019-10-24 JP JP2019193105A patent/JP2020023558A/en active Pending
-
2022
- 2022-12-22 US US18/087,564 patent/US20230181597A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170096194A (en) | 2017-08-23 |
| WO2016103260A1 (en) | 2016-06-30 |
| DK3236970T3 (en) | 2021-01-18 |
| US20230181597A1 (en) | 2023-06-15 |
| EP3236970A1 (en) | 2017-11-01 |
| AU2015369552A1 (en) | 2017-07-27 |
| IL252739A0 (en) | 2017-08-31 |
| CN107206091A (en) | 2017-09-26 |
| IL252739B (en) | 2021-03-25 |
| KR102417080B1 (en) | 2022-07-05 |
| EP3236970B1 (en) | 2020-12-16 |
| AU2015369552B2 (en) | 2020-11-19 |
| JP2020023558A (en) | 2020-02-13 |
| US20190022103A1 (en) | 2019-01-24 |
| MX2017008234A (en) | 2018-02-23 |
| CA2971824A1 (en) | 2016-06-30 |
| JP2018501312A (en) | 2018-01-18 |
| JP6609320B2 (en) | 2019-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251153A1 (en) | Pharmaceutical composition and application thereof | |
| IL252477A0 (en) | 2-aminopyrimidine compound and pharmaceutical composition and use thereof | |
| IL246383A0 (en) | Polyoxometalate and heteropolyoxometalate compositions and methods for their use | |
| GB201411197D0 (en) | Composition and use thereof | |
| HUE052359T2 (en) | Hydrofluoroolefin-based composition and use thereof | |
| IL252967B (en) | Pharmaceutical composition comprising plasminogen and uses thereof | |
| GB201421163D0 (en) | Formulations of metal complexes | |
| IL280690A (en) | Pharmaceutical compositions comprising dgla and use of same | |
| HK1245086A1 (en) | Pharmaceutical composition preparation and uses thereof | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| HK1245085A1 (en) | Pharmaceutical composition preparation and uses thereof | |
| IL252739B (en) | New metal complexes of nocardamine and their use in pharmaceutical compositions | |
| PL3145508T3 (en) | Clevidipine nanoparticles and pharmaceutical compositions thereof | |
| PL3129057T3 (en) | Glycolipids and pharmaceutical compositions thereof for use in therapy | |
| HK1245113A1 (en) | Pharmaceutical compositions and use thereof | |
| HK1243404A1 (en) | Tryptamide compositions and methods of use | |
| GB201411196D0 (en) | Composition and use thereof | |
| IL248863A0 (en) | Compositions comprising il-31 and uses thereof | |
| IL249440B (en) | Compounds and pharmaceutical compositions comprising them for use in treating neurodegenerative diseases | |
| GB2537518B (en) | Settable compositions and methods of use | |
| GB201621959D0 (en) | Compositions and their use | |
| GB201602665D0 (en) | Compositions and their use |